<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Inheritable forms of impaired sensitivity to thyroid hormone&lt;sup&gt;[1-3]&lt;/sup&gt;</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Inheritable forms of impaired sensitivity to thyroid hormone<sup>[1-3]</sup></h1>
<div class="graphic"><div class="figure"><div class="ttl">Inheritable forms of impaired sensitivity to thyroid hormone<sup>[1-3]</sup></div><div class="cntnt"><table cellspacing="0"><colgroup span="5" width="20%"></colgroup> <tbody> <tr> <td class="subtitle1" rowspan="2">Commonly used name</td> <td class="subtitle1" rowspan="2">Synonyms</td> <td class="subtitle1" rowspan="2">Gene involved and inheritance (MIM)</td> <td class="subtitle1" colspan="2">Phenotype</td> </tr> <tr> <td class="subtitle2">Consistent<br/> (pathognomonic)</td> <td class="subtitle2">Common features</td> </tr> <tr> <td class="subtitle2_left" colspan="5">Thyroid hormone cell membrane transport defects (THCMTD)</td> </tr> <tr> <td class="indent1">MCT8 defect</td> <td>Allan-Herndon-Dudley syndrome</td> <td> <ul> <li><em>MCT8</em> (<em>SLC16A2</em>) gene<br/> (<a href="https://www.omim.org/entry/300095" target="_blank">MIM #300095</a>)</li> <li>X chromosome-linked</li> </ul> </td> <td>High T<sub>3</sub>, low rT<sub>3</sub> and T<sub>4</sub>, normal or slightly elevated TSH; low BMI; hypotonia, spastic quadriplegia; not walking or, rarely, ataxic gait; dysarthria or no speech; intellectual disability</td> <td>Hypermetabolism, paroxysmal dyskinesia, reduced muscle mass, seizures, poor head control, difficulty sitting independently</td> </tr> <tr class="divider_bottom"> <td class="indent1">Idiopathic and other THCMTDs</td> <td> </td> <td> <ul> <li>To be determined</li> </ul> </td> <td>Unknown</td> <td><sup></sup></td> </tr> <tr> <td class="subtitle2_left" colspan="5">Thyroid hormone metabolism defects (THMD)</td> </tr> <tr> <td class="indent1">SBP2 defect</td> <td> </td> <td> <ul> <li><em>SBP2</em> (<em>SECISBP2</em>) gene<br/> (<a href="https://www.omim.org/entry/607693" target="_blank">MIM #607693</a>)</li> <li>Recessive</li> </ul> </td> <td>High T<sub>4</sub> and rT<sub>3</sub>, low T<sub>3</sub>, normal or slightly elevated TSH; growth retardation</td> <td>Azoospermia, immunodeficiency, photosensitivity, delayed bone maturation, myopathy, hearing impairment, delayed developmental milestones</td> </tr> <tr class="divider_bottom"> <td class="indent1">Idiopathic and other THMDs</td> <td> </td> <td> <ul> <li><em>DIO1</em> gene<br/> (<a href="https://www.omim.org/entry/147892" target="_blank">MIM 147892</a>)</li> </ul> </td> <td>High rT<sub>3</sub>:T<sub>3</sub> ratio</td> <td>Tendency for higher cholesterol, based on 2 families<sup>[4]</sup> </td> </tr> <tr> <td class="subtitle2_left" colspan="5">Thyroid hormone action defects (THAD) – Nuclear receptor and other</td> </tr> <tr> <td class="indent1">Resistance to thyroid hormone (RTH)*</td> <td>Thyroid hormone unresponsiveness, generalized RTH, RTH-beta; Refetoff syndrome</td> <td> <ul> <li><em>THRB</em> gene<br/> (<a href="https://www.omim.org/entry/190160" target="_blank">MIM #190160</a>)</li> <li>Dominant negative (rarely recessive)</li> </ul> </td> <td>High serum FT<sub>4</sub> and nonsuppressed TSH</td> <td>High serum FT<sub>3</sub> and rT<sub>3</sub>, high thyroglobulin, goiter, ADHD, tachycardia</td> </tr> <tr> <td class="indent1">nonTR-RTH<sup>¶</sup></td> <td> </td> <td> <ul> <li>Unknown</li> </ul> </td> <td>Same as above</td> <td>Same as above</td> </tr> <tr> <td class="indent1">RTH-alpha 1<sup>Δ</sup></td> <td>Congenital nongoitrous hypothyroidism 6</td> <td> <ul> <li><em>THRA</em> gene<br/> (<a href="https://www.omim.org/entry/190120" target="_blank">MIM #190120</a>)</li> <li>Dominant negative</li> </ul> </td> <td>Low serum T<sub>4</sub>:T<sub>3</sub> and T<sub>3</sub>:T<sub>4</sub> ratios; cognitive impairment, short lower limbs, delayed closure of skull sutures, bone and dental development, skeletal dysplasia; constipation; anemia</td> <td>Macrocephaly, seizures, placid behavior</td> </tr> <tr> <td class="indent1">Hypersensitivity to thyroid hormone</td> <td> </td> <td> <ul> <li>Unknown</li> </ul> </td> <td>Low FT<sub>4</sub> and FT<sub>3</sub> with normal TSH and no serum transport defects</td> <td>Normal thyroid gland</td> </tr> <tr> <td class="indent1">Idiopathic and other THADs</td> <td> </td> <td> <ul> <li>To be determined</li> </ul> </td> <td>Unknown</td> <td> </td> </tr> </tbody></table></div><div class="graphic_footnotes">MIM: Mendelian Inheritance in Man database; THCMTD: thyroid hormone cell membrane transport defect; MCT8: monocarboxylate transporter 8; T3: triiodothyronine; T4: thyroxine; THMD: thyroid hormone metabolism; TSH: thyroid-stimulating hormone; SBP2: selenocysteine insertion sequence binding protein 2; D1O1: deiodinase 1; THAD: thyroid hormone action defects; RTH: resistance to thyroid hormone; RTH-beta: resistance to thyroid hormone beta; ADHD: attention deficit hyperactivity disorder; RTH-alpha: resistance to thyroid hormone alpha.<br/>* Proposed future terminology: RTH-beta.<br/>¶ RTH without mutations in the <em>THRB</em> gene.<br/>Δ Mutations in TR-alpha 2 do not produce a phenotype, because this receptor does not bind thyroid hormone.</div><div class="graphic_reference">References:

<ol>
<li>Refetoff S, Bassett JHD, Beck-Peccoz P, et al. Classification and proposed nomenclature for inherited defects of thyroid hormone action, cell transport, and metabolism. Thyroid 2014; 24:407.</li>
<li>Refetoff S, Bassett JHD, Beck-Peccoz P, et al. Classification and proposed nomenclature for inherited defects of thyroid hormone action, cell transport, and metabolism. J Clin Endocrinol Metab 2014; 99:768.</li>
<li>Refetoff S, Bassett JHD, Beck-Peccoz P, et al. Classification and proposed nomenclature for inherited defects of thyroid hormone action, cell transport, and metabolism. Eur Thyroid J 2014; 3:7.</li>
<li>França MM, German A, Fernandes GW, et al.Human Type 1 Iodothyronine Deiodinase (DIO1) Mutations Cause Abnormal Thyroid Hormone Metabolism. Thyroid 2021; 31:202.</li>
</ol>

Republished with permission of The Endocrine Society. Copyright © 2014. Permission conveyed through Copyright Clearance Center, Inc.</div><div id="graphicVersion">Graphic 110783 Version 5.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
